The outcomes derived from numerous genome-wide association studies (GWAS) and clinical trials corroborate the pivotal involvement of TNF/IL-17/IL-23 signaling pathways in the psoriasis etiology [16,17,18,19]. This evidence concerns the gene IL17A and psoriasis.